TransCode Therapeutics Incorporated is a biopharmaceutical company that develops drugs and diagnostics for treating and identifying metastatic disease. The company's lead therapeutic candidate is TTX-MC138, a preclinical stage product for the treatment of metastatic cancer. TransCode Therapeutics was incorporated in 2016 and is headquartered in Boston, MA.
What is Transcode Therapeutics's quote symbol?
What is the 52 week high and low for Transcode Therapeutics (NASDAQ: RNAZ)?
How much is Transcode Therapeutics stock worth today?
How much is Transcode Therapeutics's stock price per share?
What is Transcode Therapeutics's Market Cap?